Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

MBCProject_0719_T1_RNA

· A

5c4c9b9a-b3eb-5b2b-a670-00990329c860

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
A
subtype
A

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • WNT_BETA_CATENIN_SIGNALING+0.460
  • NOTCH_SIGNALING+0.190
  • HEDGEHOG_SIGNALING+0.110
  • MYC_TARGETS_V2+0.070
  • MITOTIC_SPINDLE+0.040
  • MYOGENESIS+0.040
  • APICAL_JUNCTION+0.000
  • UV_RESPONSE_DN+0.000
  • APICAL_SURFACE-0.010
  • SPERMATOGENESIS-0.010

Top 10 suppressed

  • MTORC1_SIGNALING-0.610
  • OXIDATIVE_PHOSPHORYLATION-0.510
  • INTERFERON_GAMMA_RESPONSE-0.500
  • MYC_TARGETS_V1-0.500
  • IL6_JAK_STAT3_SIGNALING-0.480
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.470
  • E2F_TARGETS-0.460
  • ANDROGEN_RESPONSE-0.450
  • PROTEIN_SECRETION-0.450
  • ALLOGRAFT_REJECTION-0.440

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

9 twins match this tumor's tissue · 1 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1s0102877
melanoma-umap@29
0.955
2TCGA-90-A4ED-01A-31R-A24Z-07
lung-landscapes@6
cohortMD10.927
3AUR-AFE5-TTM9-A-1-1-R-A742-41
breast-umap@18
D0.920
4SRR4195662
colon-landscapes@1
0.920
5302722c6-102e-4b1b-845e-78920380e337
colon-landscapes@1
0.917
6SRR1404168
brain-umap@2
GTEX0.915
7ea635e80-1225-4f52-a6cf-8f4c20201240
colon-landscapes@1
0.914
8SRR4195673
colon-landscapes@1
0.912
9ERR2208935
melanoma-umap@29
0.908
10SRR8518450
breast-umap@18
A0.908

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 6 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
WNT_BETA_CATENIN_SIGNALING0.460Inavolisib— uncovered
NOTCH_SIGNALING0.190Inavolisib— uncovered
HEDGEHOG_SIGNALING0.110Inavolisib— uncovered
MYC_TARGETS_V20.070Idelalisib— uncovered
MITOTIC_SPINDLE0.040Inavolisib— uncovered
MYOGENESIS0.040Inavolisib— uncovered